Neel K Krishna

This inventor holds 15 USPTO granted patents and 22 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Realta Holdings, LLC, Eastern Virginia Medical School, Children's Health Foundation, Inc.. Active years: 2012-2025.

USPTO Granted Patents = 15 (Patent Applications = 22)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 60(Granted Patents)

Company Filing History:

Eastern Virginia Medical School

patents

1 out of 1

Children's Health Foundation, Inc.

patent

4. 1 out of 1

Eriko Life Sciences Ventures, LLC

patent

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297235 - Synthetic peptide compounds and methods of use (2025-05-13),

2. 12257290 - PIC1 inhibition of myeloperoxidase oxidative activity in an animal model (2025-03-25),

3. 11814414 - Synthetic peptide compounds and methods of use (2023-11-14),

4. 11712462 - PIC1 inhibition of myeloperoxidase oxidative activity in an animal model (2023-08-01),

5. 11135272 - PIC1 inhibition of myeloperoxidase oxidative activity in an animal model (2021-10-05),

6. 11020460 - PIC1 inhibition of myeloperoxidase oxidative activity in an animal model (2021-06-01),

7. 10947279 - Synthetic peptide compounds and methods of use (2021-03-16),

8. 10933116 - Synthetic peptide compounds and methods of use (2021-03-02),

9. 10844093 - Peptide compounds to regulate the complement system (2020-11-24),

10. 10414799 - Peptide compounds to regulate the complement system (2019-09-17),

11. 10005818 - Derivative peptide compounds and methods of use (2018-06-26),

12. 9914753 - Peptide compounds to regulate the complement system (2018-03-13),

13. 9422337 - Peptide compounds to regulate the complement system (2016-08-23),

14. 8906845 - Peptide compounds to regulate the complement system (2014-12-09),

15. 8241843 - Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof (2012-08-14),

Title: An Insight into the Innovations of Neel K Krishna

Introduction

Neel K Krishna, an accomplished inventor based in Norfolk, VA, has made significant contributions to the field of therapeutic innovations. With an impressive portfolio of 15 patents, he has focused his research on synthetic peptide compounds and their applications in treating complex diseases.

Latest Patents

Neel's latest patents showcase his pioneering work in synthetic peptide compounds and their usage for therapy and diagnostics of various diseases. The first notable invention involves the development of synthetic peptide compounds specifically designed for treating complement-mediated diseases, including inflammatory and autoimmune diseases, as well as microbial and bacterial infections. This invention revolves around modifications of a synthetic peptide comprised of 15 amino acids derived from the Polar Assortant (PA) peptide. Notably, it includes various peptide mimetics and synthetic derivatives that can be utilized to treat conditions like cystic fibrosis and acute diseases.

Additionally, another groundbreaking patent involves PIC1, a method for treating systemic lupus erythematosus and transfusion-related acute lung injury. This innovation involves administering a therapeutically effective amount of PIC1, which can modulate immune complex activation and inhibit myeloperoxidase activity in subjects.

Career Highlights

Throughout his career, Neel K Krishna has spent time working with reputable organizations. He has been associated with Realta Holdings, LLC and Eastern Virginia Medical School, both of which have provided platforms for his groundbreaking research and innovations.

Collaborations

Working alongside Neel K Krishna is his esteemed coworker Kenji Cunnion, with whom he has collaborated to develop innovative solutions in the realm of therapeutic treatments.

Conclusion

Neel K Krishna's contributions to the field of medical inventions through his synthetic peptide compounds and therapeutic methods highlight his dedication to improving patient outcomes. His ongoing innovations are likely to make a lasting impact in the healthcare industry, showcasing the vital role of inventors in advancing medical science.